Y. Matsumoto et al., ENHANCED EXPRESSION OF METALLOTHIONEIN IN HUMAN NON-SMALL-CELL LUNG CARCINOMAS FOLLOWING CHEMOTHERAPY, Anticancer research, 17(5B), 1997, pp. 3777-3780
Metallothioneins (MTs) are induced by various stimuli and probably con
fer drug resistance in tumor cells in vitro. To investigate whether MT
expression in lung cancer is induced by chemotherapy, ninety-seven su
rgical specimens from patients who had or not received chemotherapy co
ntaining cisplatin, were stained immunohistochemically for MT. In untr
eated tumors, 23% (15/64) of all tumors and 27% (15/56) of non-small-c
ell carcinoma (NSCLC) stained positive, while all eight small-cell car
cinoma (SCLC) were negative. In treated tumors, 52% (17/33) of all tum
ors, 80% (12/15) of NSCLC and 28% (5/18) of SCLC stained positive. The
proportion of positively-stained rumors was significantly higher in t
reated NSCLC compared with untreated NSCLC (P = 0.0005) and treated SC
LC (P<0.005). Our results indicate that MT expression ina eases follow
ing chemotherapy and that such expression may confer drug resistance i
n lung cancer, especially NSCLC.